Organizer
Waters Corporation
Waters Corporation
Waters Corporation, the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years.
Tags
Tips & Tricks
HPLC
Academy/Principles
LinkedIn Logo

Gathering Knowledge on the Validated or Compendial LC Method

RECORD | Already taken place Tu, 20.10.2020
Attendees will learn how to reduce out-of-specifications results by increasing understanding of their analytical procedures and controlling areas of potential variability, from sample to results.
Go to the webinar
Waters Corporation: Gathering Knowledge on the Validated or Compendial LC Method
Waters Corporation: Gathering Knowledge on the Validated or Compendial LC Method

Key learnings

  • Method transfer challenges to fulfill System Suitability Test (SST) requirements and related regulations
  • LC method risk assessment using fishbone diagrams and heat map tables
  • Applying a retrospective Analytical Quality by Design (AQbD) approach to existing methods
  • Determining the Method Operable Design Region (MODR) for compendial methods to enhance knowledge

Overview

Out-of-Specification (OOS) results in the regulated QC laboratory represent a major source of wasted resources in terms of investigation time, costs, and increased time to market.

The occurrence of OOS results originating in the lab can be significantly reduced by focusing on commonly neglected areas:

  • Is the instrumentation being used fit for its intended purpose?
  • Is the analytical procedure well understood?
  • Are the users appropriately trained?

Presenter: Alec Kettle (Pharmaceutical Specialist, Northern Europe, Waters)

Alec started his career at Waters in 2014 as a Chemistry Specialist before quickly moving into a System Sales Account Manager role in 2016 where he gained extensive knowledge and experience of the Pharmaceutical industry through account management of large Pharma and Contract Organisations. In his current role he is responsible for developing the Core Pharma, small molecule business in drug discovery, development and manufacturing/QA/QC across Northern Europe.

Waters Corporation
LinkedIn Logo
 

Related content

Comprehensive and Robust Analysis of Ultrashort- to Long-Chain PFAS, PAE, OPE, and PAH

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies, Plasmion
Industries
Environmental

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike